Editas reports Q2 2026 results, plans Australia CTN filing for EDIT-401
The gene editing company said it is on track to submit a clinical trial application this month and expects a data update in early 2027.
SEC filing
Latest
1 story
Sign inSign in1 story
The gene editing company said it is on track to submit a clinical trial application this month and expects a data update in early 2027.
SEC filing